1. Home
  2. KALA vs NINE Comparison

KALA vs NINE Comparison

Compare KALA & NINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • NINE
  • Stock Information
  • Founded
  • KALA 2009
  • NINE 2011
  • Country
  • KALA United States
  • NINE United States
  • Employees
  • KALA N/A
  • NINE N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • NINE Oilfield Services/Equipment
  • Sector
  • KALA Health Care
  • NINE Energy
  • Exchange
  • KALA Nasdaq
  • NINE Nasdaq
  • Market Cap
  • KALA 26.2M
  • NINE 23.8M
  • IPO Year
  • KALA 2017
  • NINE 2018
  • Fundamental
  • Price
  • KALA $4.82
  • NINE $0.78
  • Analyst Decision
  • KALA Strong Buy
  • NINE
  • Analyst Count
  • KALA 3
  • NINE 0
  • Target Price
  • KALA $14.00
  • NINE N/A
  • AVG Volume (30 Days)
  • KALA 74.3K
  • NINE 8.7M
  • Earning Date
  • KALA 08-05-2025
  • NINE 08-05-2025
  • Dividend Yield
  • KALA N/A
  • NINE N/A
  • EPS Growth
  • KALA N/A
  • NINE N/A
  • EPS
  • KALA N/A
  • NINE N/A
  • Revenue
  • KALA N/A
  • NINE $562,450,000.00
  • Revenue This Year
  • KALA N/A
  • NINE $3.64
  • Revenue Next Year
  • KALA N/A
  • NINE N/A
  • P/E Ratio
  • KALA N/A
  • NINE N/A
  • Revenue Growth
  • KALA N/A
  • NINE N/A
  • 52 Week Low
  • KALA $2.92
  • NINE $0.44
  • 52 Week High
  • KALA $11.20
  • NINE $2.02
  • Technical
  • Relative Strength Index (RSI)
  • KALA 55.88
  • NINE 50.71
  • Support Level
  • KALA $4.36
  • NINE $0.69
  • Resistance Level
  • KALA $5.90
  • NINE $0.81
  • Average True Range (ATR)
  • KALA 0.48
  • NINE 0.17
  • MACD
  • KALA 0.05
  • NINE -0.00
  • Stochastic Oscillator
  • KALA 39.81
  • NINE 22.30

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About NINE Nine Energy Service Inc.

Nine Energy Service Inc is a North American onshore completion and production services provider. It targets unconventional oil and gas resource development. It operates in one segment, Completion Solutions. The Completion Solutions segment offers cementing services; completion tools, including liner hangers and accessories, frac sleeves, fully composite frac plugs, and specialty open hole float equipment and centralizers and other services. It operates in the U.S, Canada, and other countries where majority of the revenue is generated from the United States.

Share on Social Networks: